https://www.selleckchem.com/pr....oducts/mitapivat.htm
72), respectively]. Finally, for NLR trend, PFS and OS for patients with NLR trend 1 were significantly longer than those patients with NLR trend ≥ 1 [HR 0.59 (95% CI 0.43-0.82) and HR 0.63 (95% CI 0.44-0.9, respectively]. At the multivariate analysis for PFS and OS, bNLR, NLR2 and NLR trend were all independent prognostic factors for PFS and OS. bNLR, NLR2 and NLR trends are independent prognostic factors for survival in patients on immunotherapy. The dynamics of NLR in patients on immunotherapy is a promising marker that need
Beğen
Yorum Yap
Paylaş
